But this is the first clinical trial to find similar results
At the same time, the lack of insurance for these drugs for the treatment of obesity reduces their affordability
Low-cost generics, telehealth platforms , daily oral formulations, microdosing strategies, and endorsements from wellness influencers & retired elite athletes are accelerating mainstream adoption and have every incentive to reframe GLP-1s as endurance tools
By reducing appetite and slowing digestion, these medications help patients feel satisfied after meals, making it easier to consume fewer calories without feeling deprived
The study cannot explain why lean body mass loss was greater with tirzepatide, which mimics the hormones GLP-1 and GIP, compared with semaglutide, which only mimics GLP-1
Depending on how well you tolerate that dose, it may be increased every four weeks, eventually reaching doses as high as 12 mg weekly in advanced stages